Annual EBIT
-$67.64 M
+$8.27 M+10.90%
December 31, 2023
Summary
- As of February 26, 2025, NXTC annual earnings before interest & taxes is -$67.64 million, with the most recent change of +$8.27 million (+10.90%) on December 31, 2023.
- During the last 3 years, NXTC annual EBIT has fallen by -$26.41 million (-64.07%).
- NXTC annual EBIT is now -334.99% below its all-time high of -$15.55 million, reached on December 31, 2017.
Performance
NXTC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$12.49 M
+$4.00 M+24.25%
September 30, 2024
Summary
- As of February 26, 2025, NXTC quarterly earnings before interest & taxes is -$12.49 million, with the most recent change of +$4.00 million (+24.25%) on September 30, 2024.
- Over the past year, NXTC quarterly EBIT has increased by +$3.29 million (+20.87%).
- NXTC quarterly EBIT is now -252.16% below its all-time high of $8.21 million, reached on March 31, 2020.
Performance
NXTC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$60.54 M
+$3.12 M+4.91%
September 30, 2024
Summary
- As of February 26, 2025, NXTC TTM earnings before interest & taxes is -$60.54 million, with the most recent change of +$3.12 million (+4.91%) on September 30, 2024.
- Over the past year, NXTC TTM EBIT has increased by +$7.10 million (+10.49%).
- NXTC TTM EBIT is now -1108.64% below its all-time high of -$5.01 million, reached on March 31, 2018.
Performance
NXTC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NXTC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.9% | +20.9% | +10.5% |
| 3 y3 years | -64.1% | +32.5% | +13.4% |
| 5 y5 years | -191.6% | -28.8% | -61.5% |
NXTC EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +10.9% | at high | +39.8% | at high | +20.3% |
| 5 y | 5-year | -80.5% | +10.9% | -252.2% | +39.8% | -169.6% | +20.3% |
| alltime | all time | -335.0% | +10.9% | -252.2% | +39.8% | -1108.6% | +20.3% |
NextCure EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.49 M(-24.2%) | -$60.54 M(-4.9%) |
| Jun 2024 | - | -$16.49 M(+4.6%) | -$63.66 M(-4.0%) |
| Mar 2024 | - | -$15.76 M(-0.2%) | -$66.33 M(-1.9%) |
| Dec 2023 | -$67.64 M(-10.9%) | -$15.79 M(+1.1%) | -$67.64 M(-2.8%) |
| Sep 2023 | - | -$15.62 M(-18.5%) | -$69.62 M(-4.9%) |
| Jun 2023 | - | -$19.16 M(+12.2%) | -$73.24 M(+1.4%) |
| Mar 2023 | - | -$17.07 M(-3.9%) | -$72.21 M(-4.9%) |
| Dec 2022 | -$75.91 M(+7.3%) | -$17.77 M(-7.6%) | -$75.91 M(+0.9%) |
| Sep 2022 | - | -$19.24 M(+6.1%) | -$75.21 M(+1.0%) |
| Jun 2022 | - | -$18.13 M(-12.7%) | -$74.48 M(+0.2%) |
| Mar 2022 | - | -$20.77 M(+21.7%) | -$74.30 M(+5.0%) |
| Dec 2021 | -$70.77 M | -$17.07 M(-7.8%) | -$70.77 M(+1.2%) |
| Sep 2021 | - | -$18.51 M(+3.1%) | -$69.93 M(+1.6%) |
| Jun 2021 | - | -$17.95 M(+4.2%) | -$68.82 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$17.23 M(+6.1%) | -$66.67 M(+61.7%) |
| Dec 2020 | -$41.23 M(+10.0%) | -$16.24 M(-6.7%) | -$41.23 M(+11.4%) |
| Sep 2020 | - | -$17.40 M(+10.1%) | -$37.00 M(+26.3%) |
| Jun 2020 | - | -$15.80 M(-292.4%) | -$29.30 M(+30.5%) |
| Mar 2020 | - | $8.21 M(-168.4%) | -$22.45 M(-40.1%) |
| Dec 2019 | -$37.48 M(+61.6%) | -$12.01 M(+23.8%) | -$37.48 M(+15.2%) |
| Sep 2019 | - | -$9.70 M(+8.3%) | -$32.54 M(+13.5%) |
| Jun 2019 | - | -$8.96 M(+31.4%) | -$28.66 M(+14.6%) |
| Mar 2019 | - | -$6.82 M(-3.6%) | -$25.00 M(+7.8%) |
| Dec 2018 | -$23.20 M(+49.2%) | -$7.07 M(+21.4%) | -$23.20 M(+43.8%) |
| Sep 2018 | - | -$5.82 M(+9.8%) | -$16.13 M(+56.5%) |
| Jun 2018 | - | -$5.30 M(+5.8%) | -$10.31 M(+105.8%) |
| Mar 2018 | - | -$5.01 M | -$5.01 M |
| Dec 2017 | -$15.55 M | - | - |
FAQ
- What is NextCure annual earnings before interest & taxes?
- What is the all time high annual EBIT for NextCure?
- What is NextCure annual EBIT year-on-year change?
- What is NextCure quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for NextCure?
- What is NextCure quarterly EBIT year-on-year change?
- What is NextCure TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for NextCure?
- What is NextCure TTM EBIT year-on-year change?
What is NextCure annual earnings before interest & taxes?
The current annual EBIT of NXTC is -$67.64 M
What is the all time high annual EBIT for NextCure?
NextCure all-time high annual earnings before interest & taxes is -$15.55 M
What is NextCure annual EBIT year-on-year change?
Over the past year, NXTC annual earnings before interest & taxes has changed by +$8.27 M (+10.90%)
What is NextCure quarterly earnings before interest & taxes?
The current quarterly EBIT of NXTC is -$12.49 M
What is the all time high quarterly EBIT for NextCure?
NextCure all-time high quarterly earnings before interest & taxes is $8.21 M
What is NextCure quarterly EBIT year-on-year change?
Over the past year, NXTC quarterly earnings before interest & taxes has changed by +$3.29 M (+20.87%)
What is NextCure TTM earnings before interest & taxes?
The current TTM EBIT of NXTC is -$60.54 M
What is the all time high TTM EBIT for NextCure?
NextCure all-time high TTM earnings before interest & taxes is -$5.01 M
What is NextCure TTM EBIT year-on-year change?
Over the past year, NXTC TTM earnings before interest & taxes has changed by +$7.10 M (+10.49%)